Antihypertensive therapy and the risk of type 2 diabetes mellitus

New England Journal of Medicine

Volumn 342, Issue 13, 2000, Pages 969-970

  Sowers, James R ^a   Bakris, George L ^b  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CHLORTALIDONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROCHLOROTHIAZIDE; THIAZIDE DIURETIC AGENT; TRIAMTERENE;

ADULT; ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; DIABETES MELLITUS; EDITORIAL; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RISK FACTOR;

ADRENERGIC BETA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; CALCIUM CHANNEL BLOCKERS; DIABETES MELLITUS, TYPE 2; DIURETICS; HUMANS; HYPERTENSION; RISK FACTORS;

EID: 0034732073     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200003303421310     Document Type: Editorial

References (15)